Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CTT Pharmaceutical Holdings Inc
CTTH
Healthcare
Biotechnology
CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. The Company's technology platform includes the development of advanced oral delivery...
thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The Wafer rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. VetWafe is used for pain management for the pet markets. This product is thin films for treating dogs and cats.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:CTTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Aug 21, 2024 12:28pm
CTT Pharmaceuticals Successfully Completes 2-Year PCAOB Audi
CTT Pharmaceuticals Successfully Completes 2-Year PCAOB Audit, Boosting Confidence in Management Team and Uplisting Potential (csimarket.com)
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Jul 15, 2024 5:08pm
CTT Signs Contract for 2 year PCAOB Audit
Ryan Khouri, CEO of CTT Pharma, stated, “This is a necessary step for giving additional transparency of CTT's financial statements to existing shareholders, new shareholders, companies that are
...more
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Jun 25, 2024 12:09pm
CTT Pharma Gives Update on NSF Grant
https://www.thenewswire.com/press-releases/1kWVFPgEm-ctt-pharma-gives-update-on-nsf-grant-for-smoke-reduction-technology.html The NSF grant program is highly competitive as it receives over 12,000
...more
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on May 16, 2024 9:11am
CTT Pharma will apply for $2.3 Million Grant for Diabetes Dr
https://www.otcmarkets.com/otcapi/company/dns/news/document/74584/content
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Mar 27, 2024 12:20pm
CTT Pharma Partners with Johns Hopkins University for NIH Gr
https://www.otcmarkets.com/stock/CTTH/news/story?e&id=2807556
(28)
•••
satchmo6
X
View Profile
View Bullboard History
Post by
satchmo6
on Nov 08, 2023 4:49pm
forgot i owned this stock CTTH
American stock that I own ARE ALL DOWN
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Nov 03, 2023 1:45pm
CTT Pharma may receive gov't contract
https://www.otcmarkets.com/otcapi/company/dns/news/document/70458/content
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Jan 30, 2023 5:03pm
First oral prototypes to ship this week
https://www.investorsobserver.com/news/qm-pr/7764806544646807
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Dec 19, 2022 3:28pm
CTT Pharma Updates On Worldwide Patent Portfolio
https://www.marketscreener.com/quote/stock/CTT-PHARMACEUTICAL-HOLDIN-120787124/news/CTT-Pharma-Updates-On-Worldwide-Patent-Portfolio-42576728/
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Dec 07, 2022 3:21pm
CTT Pharma Receives Approval for European Patent
https://stockhouse.com/news/press-releases/2022/12/06/ctt-pharma-receives-approval-for-european-patent
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Dec 01, 2022 3:33pm
CTT Pharma Starts Product Development
https://www.thenewswire.com/press-releases/1AMqFPNv5-ctt-pharma-starts-product-development.html
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Nov 24, 2022 3:16pm
CTT Pharmaceutical signs pact to make 3 oral products
https://seekingalpha.com/news/3910391-ctt-pharmaceutical-signs-pact-to-make-3-oral-products
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Nov 15, 2022 5:26pm
CTT Pharma Will Utilize Technology for Additional Products
https://www.marketscreener.com/quote/stock/CTT-PHARMACEUTICAL-HOLDIN-120787124/news/CTT-Pharma-Will-Utilize-Patented-Technology-for-Additional-Oral-Products-42303770/
(3)
•••
zubry
X
View Profile
View Bullboard History
Post by
zubry
on Oct 17, 2022 9:46am
Aurora selling dissolvable strips
(4)
•••
markenurh
X
View Profile
View Bullboard History
Post by
markenurh
on Oct 13, 2022 4:15pm
CTT Pharma Files 2 USA Patents and 2 Canadian Patents
https://www.marketscreener.com/quote/stock/CTT-PHARMACEUTICAL-HOLDIN-120787124/news/CTT-Pharma-Files-2-USA-Patents-and-2-Canadian-Patents-41986771/
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing